Xeomin

Xeomin is a purified botulinum toxin type A used for temporary muscle relaxation. It contains no complexing proteins, reducing immunogenicity risk. Commonly used for cosmetic and therapeutic indications. Suitable for intramuscular or intraglandular administration.

Xeomin is used to temporarily reduce the appearance of facial wrinkles by relaxing underlying muscles. It is also used therapeutically to treat conditions like cervical dystonia, blepharospasm, and hyperhidrosis. The product works by blocking nerve signals to targeted muscles. It is administered by healthcare professionals only.

After administration, Xeomin typically begins to take effect within 2–7 days, with peak results visible around 2 weeks. Effects generally last 3–6 months, depending on the treatment area and individual response. Patients may notice improved muscle tone and reduced wrinkle visibility in treated areas.

Xeomin should only be administered by trained healthcare professionals familiar with its use. Avoid use in patients with known hypersensitivity to botulinum toxin or its components. Pregnant or breastfeeding individuals should consult a doctor before use. Temporary side effects like redness or swelling at the injection site may occur.

Xeomin may interact with medications that affect neuromuscular transmission, such as aminoglycoside antibiotics or muscle relaxants. Alcohol and sedatives may increase the risk of side effects like dizziness or drowsiness. Always inform your healthcare provider about all medications and supplements being used.